Skip to main content
logo
International Stem Cell Corporation (ISCO)
OTCMKTS · Delayed Price · Currency is USD
0.1310
-0.0090 (-6.43%)
Dec 23, 2025, 9:30 AM EST

International Stem Cell Revenue

International Stem Cell had revenue of $2.37M in the quarter ending September 30, 2025, with 8.72% growth. This brings the company's revenue in the last twelve months to $9.39M, up 10.12% year-over-year. In the year 2024, International Stem Cell had annual revenue of $9.09M with 16.64% growth.

Revenue (ttm)
9.39M
Revenue Growth
+10.12%
P/S Ratio
0.11
Revenue / Employee
293.47K
Employees
32
Market Cap
1.05M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.09M1.30M16.64%
Dec 31, 20237.79M-391.00K-4.78%
Dec 31, 20228.18M1.00M13.99%
Dec 31, 20217.18M48.00K0.67%
Dec 31, 20207.13M-2.34M-24.75%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
American Oncology Network1.76B
Veradigm588.02M
Glass House Brands196.17M
Global Cord Blood196.10M
Elite Pharmaceuticals122.89M
Silence Therapeutics25.83M
OpGen9.00M
Northwest Biotherapeutics937.00K
Revenue Rankings

International Stem Cell News

More News